These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22078363)

  • 41. Effective identification of Gram-negative bacterial type III secreted effectors using position-specific residue conservation profiles.
    Yang X; Guo Y; Luo J; Pu X; Li M
    PLoS One; 2013; 8(12):e84439. PubMed ID: 24391954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Features and algorithms: facilitating investigation of secreted effectors in Gram-negative bacteria.
    Zhao Z; Hu Y; Hu Y; White AP; Wang Y
    Trends Microbiol; 2023 Nov; 31(11):1162-1178. PubMed ID: 37349207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computational prediction of type III and IV secreted effectors in gram-negative bacteria.
    McDermott JE; Corrigan A; Peterson E; Oehmen C; Niemann G; Cambronne ED; Sharp D; Adkins JN; Samudrala R; Heffron F
    Infect Immun; 2011 Jan; 79(1):23-32. PubMed ID: 20974833
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new feature selection method for computational prediction of type III secreted effectors.
    Yang Y; Qi S
    Int J Data Min Bioinform; 2014; 10(4):440-54. PubMed ID: 25946888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The type III needle and the damage done.
    Johnson S; Deane JE; Lea SM
    Curr Opin Struct Biol; 2005 Dec; 15(6):700-7. PubMed ID: 16263265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-accuracy prediction of bacterial type III secreted effectors based on position-specific amino acid composition profiles.
    Wang Y; Zhang Q; Sun MA; Guo D
    Bioinformatics; 2011 Mar; 27(6):777-84. PubMed ID: 21233168
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of novel type III effectors using latent Dirichlet allocation.
    Yang Y
    Comput Math Methods Med; 2012; 2012():696190. PubMed ID: 22997537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Type II secretion: a protein secretion system for all seasons.
    Cianciotto NP
    Trends Microbiol; 2005 Dec; 13(12):581-8. PubMed ID: 16216510
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioinformatics correctly identifies many type III secretion substrates in the plant pathogen Pseudomonas syringae and the biocontrol isolate P. fluorescens SBW25.
    Vinatzer BA; Jelenska J; Greenberg JT
    Mol Plant Microbe Interact; 2005 Aug; 18(8):877-88. PubMed ID: 16134900
    [TBL] [Abstract][Full Text] [Related]  

  • 50. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
    Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural biology of bacterial secretion systems in gram-negative pathogens--potential for new drug targets.
    Durand E; Verger D; Rêgo AT; Chandran V; Meng G; Fronzes R; Waksman G
    Infect Disord Drug Targets; 2009 Nov; 9(5):518-47. PubMed ID: 19594425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishing order for type III secretion substrates--a hierarchical process.
    Thomas NA; Brett Finlay B
    Trends Microbiol; 2003 Aug; 11(8):398-403. PubMed ID: 12915098
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantitative mass spectrometry catalogues Salmonella pathogenicity island-2 effectors and identifies their cognate host binding partners.
    Auweter SD; Bhavsar AP; de Hoog CL; Li Y; Chan YA; van der Heijden J; Lowden MJ; Coombes BK; Rogers LD; Stoynov N; Foster LJ; Finlay BB
    J Biol Chem; 2011 Jul; 286(27):24023-35. PubMed ID: 21566117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic and molecular analysis of GogB, a phage-encoded type III-secreted substrate in Salmonella enterica serovar typhimurium with autonomous expression from its associated phage.
    Coombes BK; Wickham ME; Brown NF; Lemire S; Bossi L; Hsiao WW; Brinkman FS; Finlay BB
    J Mol Biol; 2005 May; 348(4):817-30. PubMed ID: 15843015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of autocleavage in the function of a type III secretion specificity switch protein in Salmonella enterica serovar Typhimurium.
    Monjarás Feria JV; Lefebre MD; Stierhof YD; Galán JE; Wagner S
    mBio; 2015 Oct; 6(5):e01459-15. PubMed ID: 26463164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T3SEdb: data warehousing of virulence effectors secreted by the bacterial Type III Secretion System.
    Tay DM; Govindarajan KR; Khan AM; Ong TY; Samad HM; Soh WW; Tong M; Zhang F; Tan TW
    BMC Bioinformatics; 2010 Oct; 11 Suppl 7(Suppl 7):S4. PubMed ID: 21106126
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vibrio parahaemolyticus Senses Intracellular K
    Tandhavanant S; Matsuda S; Hiyoshi H; Iida T; Kodama T
    mBio; 2018 Jul; 9(4):. PubMed ID: 30042203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond.
    Cianciotto NP; White RC
    Infect Immun; 2017 May; 85(5):. PubMed ID: 28264910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Terminal reassortment drives the quantum evolution of type III effectors in bacterial pathogens.
    Stavrinides J; Ma W; Guttman DS
    PLoS Pathog; 2006 Oct; 2(10):e104. PubMed ID: 17040127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of T4SS Effector Proteins for
    Esna Ashari Z; Brayton KA; Broschat SL
    Front Microbiol; 2019; 10():1391. PubMed ID: 31293540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.